Search
  • Raye Elaine, BCPA

October is Breast Cancer Awareness Month

As a healthcare provider I have seen the devastation and the triumphs of women with breast cancer. I have been blessed in that no one in my family has had to battle this devastating disease. Anytime I find myself feeling unhappy with my breasts for some reason I take a moment to offer profound gratitude to have two healthy breasts. Please take time to get your mammograms done and practice breast self-exams. Help other women to get the care they need by donating below.


Facts About Breast Cancer In The United States


  • In 2022, an estimated 287,500 new cases of invasive breast cancer will be diagnosed in women in the U.S. as well as 51,400 new cases of non-invasive (in situ) breast cancer.

  • 65% of breast cancer cases are diagnosed at a localized stage (there is no sign that the cancer has spread outside of the breast), for which the 5-year relative survival rate is 99%.

  • This year, an estimated 43,550 women will die from breast cancer in the U.S.

  • Although rare, men get breast cancer too. In 2022, an estimated 2,710 men will be diagnosed with breast cancer in the U.S. and approximately 530 men will die from breast cancer.

  • 1 in 8 women in the United States will be diagnosed with breast cancer in her lifetime

  • Breast cancer is the most common cancer in American women, except for skin cancers. It is estimated that in 2022, approximately 30% of all new women cancer diagnoses will be breast cancer.

  • There are over 3.8 million breast cancer survivors in the United States.

  • On average, every 2 minutes a woman is diagnosed with breast cancer in the United States.

This year we RISE to ensure every woman has access to the screenings she needs and the support she deserves. When we RISE, we Rally in Screening Everyone.

Are you ready to RISE?


Click here to donate:

Click to Donate to National Breast Cancer Foundation


2 views0 comments

Recent Posts

See All

Many people may not be aware that the pharmaceutical companies have been ruthlessly increasing the cost of life sustaining insulin far beyond the actual cost of production. Insulin prices can range fr